The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
HADLIMA adalimumab 40 mg/0.4 mL solution for injection in pre-filled syringe (2023-24)
Product name
HADLIMA adalimumab 40 mg/0.4 mL solution for injection in pre-filled syringe
Sponsor name
Samsung Bioepis AU Pty Ltd
Year Range
2023-24